Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®


Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

Simon, James A.; Al-Hendy, Ayman; Archer, David F.; Barnhart, Kurt T.; Bradley, Linda D.; Carr, Bruce R.; Dayspring, Thomas; Feinberg, Eve C.; Gillispie, Veronica; Hurtado, Sandra; Kim, JinHee; Liu, Ran; Owens, Charlotte D.; Muneyyirci-Delale, Ozgul; Wang, Alice; Watts, Nelson B.; Schlaff, William D.

Author Information
Obstetrical & Gynecological Survey: September 2020 - Volume 75 - Issue 9 - p 545-547
doi: 10.1097/01.ogx.0000696612.60869.1b
  • Buy


Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.